Agritek Holdings, Inc. (OTC PINK:AGTK) has filed its Annual Report on Form 10-K for the year ending December 31, 2019. The report includes consolidated financial statements and signals the company's intent to return to fully reporting compliance and pursue an uplisting. Additionally, the acquisition of Full Spectrum Biosciences Inc. has been completed, enhancing its capabilities in producing low-cost CBG/CBGA cannabis compounds. This positioning allows Agritek to capitalize on favorable cannabis legislation and expand into multiple distribution channels.
Agritek Holdings, Inc (OTC PINK: AGTK) has announced plans to finalize its 10K Annual Report and Quarterly reports for 2019 and 2020, aiming to regain fully reporting status this month. The company is optimistic about future growth opportunities in the cannabis sector, bolstered by recent legislative changes. A joint venture with Biomedican will enable Agritek to produce low-cost, pharmaceutical-grade CBG/CBGA cannabis compounds, with bulk shipping expected in late 2021. Effective legal and strategic measures are in place to ensure compliance and capitalize on the cannabis market.